
Analysts Viewpoint
Potential Price Increase for Recursion Pharmaceuticals Inc (RXRX) After Recent Insider Activity
Recursion Pharmaceuticals Inc’s filing revealed that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.84 million on